Advanced search
Publication Cover
Journal of Market Access & Health Policy Volume 6, 2018 - Issue 1
Journal homepage
2,187
Views
9
CrossRef citations to date
0
Altmetric
Original Research Article

The potential price and access implications of the cost-utility and budget impact methodologies applied by NICE in England and ICER in the US for a novel gene therapy in Parkinson’s disease

Jesper JørgensenHealth Economics and Market Access Department, Cell and Gene Therapy Catapult, London, UKView further author information
,
Spiros ServosBusiness Development Department, Oxford BioMedica (UK), Oxford, UKView further author information
&
Panos KefalasHealth Economics and Market Access Department, Cell and Gene Therapy Catapult, London, UKCorrespondence[email protected]
View further author information
Article: 1500419 | Received 12 Apr 2018, Accepted 09 Jul 2018, Published online: 06 Aug 2018

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.